We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01076257
Recruitment Status : Completed
First Posted : February 26, 2010
Last Update Posted : July 31, 2012
Sponsor:
Information provided by (Responsible Party):
Chang Gung Memorial Hospital

Brief Summary:
This research centers on the comparison of the immediate efficacy (right after therapy) and the maintained efficacy (3 months and 6 months) between "Modified Constraint-Induced Movement Therapy" (mCIMT) group and control group at different age.

Condition or disease Intervention/treatment
Brain Damage Cerebral Palsy Traumatic Brain Damage Behavioral: Modified Constraint-induced Movement Therapy

Detailed Description:

"Modified Constraint-Induced Movement Therapy" is one of the most recent treatments for children with Brain damage.

This well-designed and follow-up RCT study compared home-based CIT with a control intervention (traditional rehabilitation, TR) by combining kinematic analysis and clinical evaluation, which is possible to examine whether functional improvement is accompanied by a change in motor control. We hypothesized that home-based CIT would induce better motor control strategies (shorter RT, MT, lesser MUs, MGA, and PMGA, and larger peak velocity (PV)) for greater functional gains than TR. Furthermore, the beneficial effects would be maintained at 3 and 6 months of follow-up. Findings of this study allow clinicians to understand the underlying motor control changes for functional improvement after home-based CIT.


Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 48 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Efficacy of Modified Constraint-induced Movement Therapy in Children With Brain Damage: Evidence of Kinematic Study
Study Start Date : June 2009
Primary Completion Date : July 2010
Study Completion Date : July 2010

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: Constraint-induced Movement Therapy Behavioral: Modified Constraint-induced Movement Therapy

Home based CIT

  1. Restriction of the less affected limb
  2. Intensive practice using affected limb
  3. Positive experience
  4. Functional task (task)
Other Names:
  • Constraint-Induced Therapy
  • Forced-use Therapy
  • Immobilization Therapy
Transditional rehabilitation Behavioral: Modified Constraint-induced Movement Therapy

Home based CIT

  1. Restriction of the less affected limb
  2. Intensive practice using affected limb
  3. Positive experience
  4. Functional task (task)
Other Names:
  • Constraint-Induced Therapy
  • Forced-use Therapy
  • Immobilization Therapy



Primary Outcome Measures :
  1. Bruininks-Oseretsky Test of Motor Proficiency (BOTMP) [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]
    All children underwent a series of upper limb assessments, including kinematic analysis and functional measures (primary and secondary outcomes), before the start of the intervention (pretreatment). An occupational therapist blinded to group assignment was trained to administer these measures. All participants underwent these assessments at 4 weeks immediately after intervention (post-treatment), and at 12-week follow-up and 24-week follow-up.

  2. Peabody Development Motor Scales, subtest fine motor (PDMS-Ⅱ) [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]
  3. Kinematic analysis [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]

Secondary Outcome Measures :
  1. Pediatric Motor Activity Log ( PMAL ) [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]
    All children underwent a series of upper limb assessments, including kinematic analysis and functional measures (primary and secondary outcomes), before the start of the intervention (pretreatment). An occupational therapist blinded to group assignment was trained to administer these measures. All participants underwent these assessments at 4 weeks immediately after intervention (post-treatment), and at 12-week follow-up and 24-week follow-up.

  2. Pediatric Functional Independence Measure ( WeeFIM ) [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]
  3. Cerebral palsy quality of life (CPQoL) [ Time Frame: 4 weeks (post-treatment), 12 week, 24 week ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   4 Years to 15 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Development learned-nonuse
  2. Age range 4y/o-15y/o
  3. Wrist ext 10˚, MP j't ext 10˚ in affected U/E
  4. Can fallow up the simple instruction
  5. Modified Ashworth Scale ≦2
  6. Pediatric Motor Activity Log ≦2.5 (average)

Exclusion Criteria:

  1. Related muscle skeleton surgery
  2. Selective dorsal rhizotomy
  3. Botulinum toxin in 6 months
  4. Visual perception impaired
  5. Hearing perception impaired
  6. Balance ability impaired (in constrained)

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01076257


Locations
Taiwan
Chang Gung Memorial Hospital
Taoyuan, Taiwan, 333
Sponsors and Collaborators
Chang Gung Memorial Hospital
Investigators
Principal Investigator: Chia-Ling chen, MD,PhD Chang Gung Memorial Hospital

Responsible Party: Chang Gung Memorial Hospital
ClinicalTrials.gov Identifier: NCT01076257     History of Changes
Other Study ID Numbers: 97-1823B
First Posted: February 26, 2010    Key Record Dates
Last Update Posted: July 31, 2012
Last Verified: May 2010

Keywords provided by Chang Gung Memorial Hospital:
brain damage
constraint induced movement therapy
kinematic
function
outcome
Quality of life

Additional relevant MeSH terms:
Cerebral Palsy
Brain Injuries
Brain Injuries, Traumatic
Brain Damage, Chronic
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Wounds and Injuries